Got the blues? You can still see blue: Popular paper on sadness, color perception retracted

home_coverA paper published in August that caught the media’s eye for concluding that feeling sad influences how you see colors has been retracted, after the authors identified problems that undermined their findings.

The authors explain the problems in a detailed retraction note released today by Psychological Science. They note that they found sadness influenced how people see blues and yellows but not reds and greens, but they needed to compare those findings to each other in order to prove the validity of the conclusion. And once they performed that additional test, the conclusion no longer held up.

In the retraction note for “Sadness impairs color perception,” the editor reinforces that there was no foul play:

Continue reading Got the blues? You can still see blue: Popular paper on sadness, color perception retracted

Mega-correction to several images in gastric cancer study

20.cover

A journal has issued a rather large correction — what we call “mega-correction” — to a 2014 paper on a gastric cancer biomarker that fixes problems with several of the study’s figures.

The authors write that despite the corrections, “the results and conclusions put forth in the article remain unchanged.”

The paper, “TMEFF2 Deregulation Contributes to Gastric Carcinogenesis and Indicates Poor Survival Outcome” explored the role of TMEFF2 in gastric cancer. The researchers found that the protein acts as a tumor suppressor, and low levels can indicate the presence of cancerous cells.

Here’s the full correction notice, published by Clinical Cancer Research in August:

Continue reading Mega-correction to several images in gastric cancer study

University finds “preponderance of evidence” of misconduct by child psychiatrist

JPN39_2_CoverAn investigation at the University of Illinois at Chicago has found “a preponderance of evidence” that a psychiatrist who has received millions of dollars in federal funding has committed misconduct.

One paper co-authored by Mani Pavuluri, the director of the Pediatric Mood Disorders Program, has been officially retracted so far, from the Journal of Psychiatry & Neuroscience. UIC has requested that two others be retracted as well. None of the child participants in the three papers received medication as part of the research, but the Journal of Psychiatry & Neuroscience paper was pulled after the investigation found that Pavuluri had misrepresented how much medication some children had taken outside of the study.

On Tuesday, after we’d learned of the first retraction, Pavuluri told Retraction Watch that she didn’t “want mountains made out of molehills,” but admitted to “a bit of an [Institutional Review Board] infraction.”

The retraction note from the Journal of Psychiatry & Neuroscience lays the blame squarely on Pavuluri’s shoulders:

Continue reading University finds “preponderance of evidence” of misconduct by child psychiatrist

Journal reviewing papers by researcher who sexually assaulted disabled author

Screen Shot 2015-11-03 at 12.10.00 PMA disability journal is “paying significant attention” to papers authored by Anna Stubblefield, a former Rutgers researcher recently convicted of sexually assaulting a disabled man who participated in her research.

Stubblefield was convicted of sexually assaulting “DJ,” a man in his thirties with cerebral palsy who was “declared by the state to have the mental capacity of a toddler,” according to a lengthy piece in the New York Times. Stubblefield and DJ published papers in Disability Studies Quarterly; in one, Stubblefield describes a controversial technique which she claimed helped DJ communicate. But when she eventually used the technique to say DJ was in love with her, his family took her to court, and she was convicted of aggravated sexual assault.

Here is the note from Disability Studies Quarterly, which was published this morningContinue reading Journal reviewing papers by researcher who sexually assaulted disabled author

Cholesterol paper duplicated; “The authors believed that they had taken the necessary steps to withdraw.”

Biological Reviews

A review journal is pulling a 2013 article about advances in researchers’ understanding of cholesterol after seeing the same article in another journal.

Although the retracted paper appeared first — online in Biological Reviews in February, 2013 — the journal decided to retract it after learning the authors had initially submitted it elsewhere. The first submission was eventually published (with the exception of one author) in 2014 in Frontiers in Bioscience

The authors say they “believed that they had taken the necessary steps to withdraw their paper from Frontiers in Bioscience before they submitted to Biological Reviews in June 2012.” Here’s more from the retraction notice:

Continue reading Cholesterol paper duplicated; “The authors believed that they had taken the necessary steps to withdraw.”

Sex addiction article retracted, republished

Screen Shot 2015-10-14 at 2.01.12 PMAn open-access journal with a speedy peer review process has been having some issues with a retracted article on the biology of sex addiction.

Here’s the simple timeline of events: “Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics,” a review article, was published by Cureus in July, following a two-day peer review. In the weeks that followed, the paper received a number of criticisms. So the journal quietly corrected it, then issued a formal correction, then retracted the paper — and now, finally, has republished it. The editor of the journal, Stanford professor emeritus John Adler, admitted the “decision was dumb” to initially fix the article without an alert, but it was ultimately doomed by “political” issues — namely, a larger debate over whether or not “sex addiction” exists at all.

We’ll start with the retraction. According to the note, it stems from the mistaken characterization of how sex addition — “hypersexuality” — is described in the current “bible” of psychiatry:

Continue reading Sex addiction article retracted, republished

Plagiarism was “not an intentional act,” says first author of retracted TB paper

logoA 2013 review article about tuberculosis is being retracted for “unacknowledged re-use of significant portions of text” from another article, which the first author said wasn’t intentional.

Sayantan Ray, based at Medical College and Hospital, Kolkata in India, told us that “most of the unchanged text” is present in sections written by junior co-authors. Since there doesn’t appear to be any attempt to cover it up, he argued anyone responsible for the plagiarism must not have realized it was wrong:

You can appreciate that this type of obvious similarity can only happen when the concerned person [does] not have any idea about [the] plagiarism issue.

According to the notice, published by Therapeutics and Clinical Risk Management, most of the re-used text appears to have come from a 2012 paper in the Indian Journal of Medical Research. Here’s more from the notice:

Continue reading Plagiarism was “not an intentional act,” says first author of retracted TB paper

Journal retracts — and republishes — small study on gamma rays for OCD

Screen Shot 2015-10-28 at 8.40.00 PMJAMA Psychiatry has retracted and republished a paper on a cutting-edge procedure for patients with obsessive compulsive disorder.

In the original paper, the authors claimed that three out of eight patients who underwent a procedure that used gamma rays to kill brain cells showed improvements 12 months later (versus zero in the group who underwent a “sham” procedure). But after a reader noticed an “inadvertent” error in the calculation of how many patients had improved, the authors realized that only two of the patients had responded meaningfully to the procedure.

The new results “did not reach statistical significance,” the authors write in a “Notice of Retraction and Replacement.”  JAMA Psychiatry published it yesterday, along with a new version of the articlea letter from psychiatrist Christopher Baethge pointing out the error, and an editorial. The original article is available in the supplemental material of the new version, with the errors highlighted.

Here’s the note in full for “Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized clinical trial,” which explains the error:

Continue reading Journal retracts — and republishes — small study on gamma rays for OCD

After court verdict, BMJ retracts 26-year-old paper

downloadToday, The BMJ retracted a 1989 paper about the role of breastfeeding and formula in infant eczema — 20 years after the data were called into question by a university report.

However, the report was kept secret — due, by some accounts, to alleged threats of a lawsuit. That is, until this year, when author Ranjit Kumar Chandra — who once dubbed himself the “father of nutritional immunology” — lost a $132 million libel case. That case, against the Canadian Broadcasting Company (CBC) for airing a three-part documentary series on allegations of fraud against Chandra, pushed the report by his former employer Memorial University of Newfoundland into the public domain.

At 26 years, the BMJ retraction is a runner up for the longest amount of time a journal has taken to retract a paper. (We know of another retraction that was 27 years in the making, and a scientist who requested the retraction of some passages of a 1955 article in 2007, after the article became fodder for creationists.)

Here’s the first part of the retraction note:

Continue reading After court verdict, BMJ retracts 26-year-old paper

Bone researcher manipulated data in JAMA study, says investigation

Screen Shot 2015-10-27 at 10.53.53 AMA bone researcher manipulated data in a 2011 JAMA study about an inexpensive treatment for osteoporosis. That’s the conclusion of an investigation at the researcher’s former workplace, the Women’s College Hospital in Toronto, the Toronto Star reports.

The study — led and manipulated by Sophie Jamal — followed 243 women over two years, as they applied nitroglycerin ointment once a day. The ointment is currently used to prevent chest pain and treat anal fissure pain by relaxing blood vessels; Jamal’s study concluded it could help patients with osteoporosis, too:

Among postmenopausal women, nitroglycerin ointment modestly increased [bone mineral density] and decreased bone resorption.

But even the modest effect was too good to be true. Continue reading Bone researcher manipulated data in JAMA study, says investigation